chr1-23692463-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000458455.2(RPL11):​c.-173T>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0177 in 975,720 control chromosomes in the GnomAD database, including 354 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.034 ( 177 hom., cov: 32)
Exomes 𝑓: 0.015 ( 177 hom. )

Consequence

RPL11
ENST00000458455.2 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.0720

Publications

0 publications found
Variant links:
Genes affected
RPL11 (HGNC:10301): (ribosomal protein L11) Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a ribosomal protein that is a component of the 60S subunit. The protein belongs to the L5P family of ribosomal proteins. It is located in the cytoplasm. The protein probably associates with the 5S rRNA. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. [provided by RefSeq, Dec 2010]
RPL11 Gene-Disease associations (from GenCC):
  • Diamond-Blackfan anemia 7
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia
  • Diamond-Blackfan anemia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 1-23692463-T-C is Benign according to our data. Variant chr1-23692463-T-C is described in ClinVar as Benign. ClinVar VariationId is 1251916.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0836 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000458455.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RPL11
NM_000975.5
MANE Select
c.7-146T>C
intron
N/ANP_000966.2
RPL11
NM_001199802.1
c.7-149T>C
intron
N/ANP_001186731.1P62913-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RPL11
ENST00000458455.2
TSL:1
c.-173T>C
5_prime_UTR
Exon 1 of 5ENSP00000398888.2Q5VVC8
RPL11
ENST00000643754.2
MANE Select
c.7-146T>C
intron
N/AENSP00000496250.1P62913-1
RPL11
ENST00000374550.8
TSL:1
c.7-149T>C
intron
N/AENSP00000363676.4P62913-2

Frequencies

GnomAD3 genomes
AF:
0.0343
AC:
5217
AN:
152128
Hom.:
176
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0858
Gnomad AMI
AF:
0.00329
Gnomad AMR
AF:
0.0247
Gnomad ASJ
AF:
0.00979
Gnomad EAS
AF:
0.0419
Gnomad SAS
AF:
0.00848
Gnomad FIN
AF:
0.00914
Gnomad MID
AF:
0.0886
Gnomad NFE
AF:
0.0117
Gnomad OTH
AF:
0.0350
GnomAD4 exome
AF:
0.0146
AC:
11992
AN:
823474
Hom.:
177
Cov.:
11
AF XY:
0.0141
AC XY:
5977
AN XY:
424394
show subpopulations
African (AFR)
AF:
0.0844
AC:
1753
AN:
20774
American (AMR)
AF:
0.0166
AC:
550
AN:
33232
Ashkenazi Jewish (ASJ)
AF:
0.00774
AC:
152
AN:
19648
East Asian (EAS)
AF:
0.0373
AC:
1276
AN:
34170
South Asian (SAS)
AF:
0.00886
AC:
581
AN:
65566
European-Finnish (FIN)
AF:
0.0102
AC:
386
AN:
37886
Middle Eastern (MID)
AF:
0.0390
AC:
125
AN:
3208
European-Non Finnish (NFE)
AF:
0.0110
AC:
6280
AN:
570328
Other (OTH)
AF:
0.0230
AC:
889
AN:
38662
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
579
1158
1738
2317
2896
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
192
384
576
768
960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0344
AC:
5234
AN:
152246
Hom.:
177
Cov.:
32
AF XY:
0.0329
AC XY:
2447
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.0859
AC:
3567
AN:
41516
American (AMR)
AF:
0.0247
AC:
377
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00979
AC:
34
AN:
3472
East Asian (EAS)
AF:
0.0418
AC:
217
AN:
5188
South Asian (SAS)
AF:
0.00828
AC:
40
AN:
4832
European-Finnish (FIN)
AF:
0.00914
AC:
97
AN:
10610
Middle Eastern (MID)
AF:
0.0918
AC:
27
AN:
294
European-Non Finnish (NFE)
AF:
0.0117
AC:
796
AN:
68020
Other (OTH)
AF:
0.0361
AC:
76
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
243
486
730
973
1216
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0279
Hom.:
16
Bravo
AF:
0.0367
Asia WGS
AF:
0.0410
AC:
142
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
6.8
DANN
Benign
0.42
PhyloP100
-0.072
PromoterAI
0.019
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs78796509; hg19: chr1-24018953; API